Sermorelin
10mgPrecios por Volumen
Por unidad — descuentos por volumen aplicados automáticamentePrecios mayoristas disponibles para cuentas aprobadas
Acerca de Sermorelin
Sermorelin (GRF 1-29 NH2) is a synthetic 29-amino acid peptide corresponding to the first 29 amino acids of naturally occurring growth hormone-releasing hormone (GHRH). It is the shortest fully functional fragment of GHRH and is studied for its ability to stimulate endogenous pituitary growth hormone secretion while maintaining normal pulsatile GH release patterns. Investigated in preclinical and clinical research for age-related GH decline, body composition, sleep architecture, and neuroendocrine axis regulation.
Preguntas Frecuentes
Todos los péptidos de Signal se someten a rigurosas pruebas de terceros y tienen una pureza garantizada ≥99%. Cada lote incluye un Certificado de Análisis (COA) verificado a través del sistema de verificación blockchain de AuthentiChain.
Los pedidos realizados antes de las 12PM EST se envían el mismo día mediante logística de cadena de frío. Los productos se envían en empaques aislados con hielo seco para mantener la integridad de la temperatura. La entrega estándar es de 1 a 3 días hábiles.
Las cuentas aprobadas tienen acceso a términos de pago flexibles que incluyen NET 30, transferencia bancaria y tarjeta de crédito. Los precios basados en volumen se aplican automáticamente al momento del pago según la cantidad de su pedido.
Por supuesto. Contacte a su gerente de cuenta dedicado o escriba a info@signalpeps.co con el nombre del producto y número de lote. Los COA también están disponibles digitalmente a través de nuestra insignia de verificación AuthentiChain en cada página de producto.
Published Study Findings on Sermorelin
Detailed Research & Citations
In-depth findings from peer-reviewed preclinical and clinical studies
Sermorelin (GRF 1-29 NH2) is a synthetic 29-amino acid peptide corresponding to the biologically active N-terminal segment of human growth hormone-releasing hormone (GHRH). It is the shortest fully functional fragment of GHRH capable of stimulating pituitary somatotroph cells to release endogenous growth hormone while preserving natural pulsatile secretion patterns.
Pulsatile Growth Hormone Stimulation
Sermorelin stimulates the pituitary gland to release growth hormone in a physiological pulsatile manner via GHRH receptor activation, maintaining normal feedback mechanisms. Unlike exogenous GH, it does not suppress endogenous GH production or desensitize the GH axis.
BioDrugs (2001)Dose-Dependent GH Elevation
Clinical studies demonstrated dose-dependent increases in serum GH and IGF-1 levels following subcutaneous sermorelin administration. Chronic daily administration for 6–12 months produced sustained elevations in IGF-1 and IGFBP-3 in GH-deficient adults.
BioDrugs (2001)Lean Mass & Fat Reduction
In a randomized, double-blind study of healthy elderly subjects, sermorelin administration increased lean body mass, reduced trunk adiposity, and improved body composition indices over a 4-month treatment period. These changes were associated with sustained IGF-1 elevation.
Journal of Clinical Endocrinology & Metabolism (1997)Enhanced Slow-Wave Sleep
Sermorelin and GHRH analogs have been shown to promote non-REM slow-wave sleep (stages 3–4) and increase nocturnal GH secretion. Sleep studies demonstrated improved sleep efficiency and enhanced restorative sleep architecture in elderly subjects.
Neuroendocrinology (1992)Clinical Safety Profile
Sermorelin has demonstrated a favorable safety profile across multiple clinical trials. As it stimulates endogenous GH through natural feedback pathways, it avoids the supraphysiological GH levels associated with exogenous GH administration. Common side effects are limited to injection site reactions and transient flushing.
BioDrugs (2001)Age-Related GH Decline Reversal
Sermorelin has been studied as a physiological approach to reversing the age-related decline in GH secretion (somatopause). In elderly populations, chronic sermorelin restored GH responsiveness and IGF-1 levels toward youthful ranges without tachyphylaxis over extended treatment periods.
Journal of Clinical Endocrinology & Metabolism (1997)View All 3 Sources
- Sermorelin: A Review of its Use in the Diagnosis and Treatment of Children with Idiopathic Growth Hormone Deficiency
- Effects of Growth Hormone-Releasing Hormone on Body Composition and Metabolic Parameters in Healthy Elderly Subjects
- Growth Hormone-Releasing Hormone Improves the Quality of Sleep in Elderly Subjects
All findings above are sourced from peer-reviewed journals for educational reference. This product is for research purposes only — not for human consumption. Preclinical results may not translate to human outcomes.
Identidad Química
Cómo Ordenar
Tres simples pasos para acceder a péptidos de investigación premium
Solicite una Cuenta
Envíe una solicitud rápida con los datos de su empresa. Toma menos de 2 minutos.
Sea Aprobado
Nuestro equipo revisa las solicitudes en 1–2 días hábiles. Recibirá un correo una vez aprobado.
Realice su Pedido
Explore el catálogo, seleccione cantidades y pague. Los precios por volumen se aplican automáticamente.
Todos los productos son solo para investigación y uso en laboratorio. No destinados para consumo humano o animal. Solo profesionales calificados deben manejar estos productos.
